News

Rally Labs launches Blowfish for Hangovers

BY Michael Johnsen

NEW YORK — Rally Labs recently introduced its Blowfish for Hangovers, a morning-after remedy that has a bit of a cult following in New York, into the drug channel the company noted. 

The Blowfish formulation contains a combination of aspirin and caffeine in an effervescent tablet specifically formulated for hangovers. The buffered formula helps rehydrate, restore alertness and provide relief for a headache, Rally Labs noted. 

Upon waking, two fully-dissolved tablets in 16 oz. of water have consumers feeling better in as little as 15 minutes, Rally Labs added. 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Vivus launches Qsymia in Costco, Walgreens stores

BY Alaric DeArment

MOUNTAIN VIEW, Calif. — A drug for treating obesity has become available through a network of about 8,000 retail pharmacies around the country, the drug’s manufacturer said Monday.

Vivus said the drug, Qsymia (phentermine; topiramate) extended-release capsules would be available at Costco and Walgreens stores, including Duane Reade stores. The launch is happening ahead of the previously announced mid-July launch date.

"Today is the start of a new process that simplifies prescribing and improves access for patients in need of Qsymia, an effective and well-tolerated treatment for chronic weight management," Vivus president Peter Tam said. "With the retail expansion, we remain committed to increasing the availability of Qsymia in thousands of additional retail pharmacies nationwide in the coming weeks."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Dr. Reddy’s launches generic epilepsy drug

BY Alaric DeArment

HYDERABAD, India — Dr. Reddy’s Labs has launched a generic drug for treating epilepsy, the company said.

The Indian generic drug maker announced the launch of lamotrigine extended-release tablets in the 25-mg, 50-mg, 100-mg, 200-mg and 300-mg strengths. The drug is being distributed in bottle sizes of 30.

Lamotrigine extended-release tablets are a generic version of GlaxoSmithKline’s Lamictal XR, branded and generic versions of which had sales of $300.5 million during the 12-month period that ended in April, according to IMS Health.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES